-
Southeast Asia has been a hot spot for drug-resistant malaria in the past. Now researchers in Thailand worry that a superstrain resistant to the last, best malaria treatments could undermine progress made against the mosquito-borne disease.
-
This month the Global Fund board will decides whether to continue or scrap a $225 million program that subsidizes malaria drugs in Africa. A new analysis bolsters a major criticism of the project. In some places, most of the subsidized drugs have been going to people without malaria.
-
A test of subsidies in Africa for the most effective malaria drug treatment is drawing fire. Supporters say the subsidies helped improve access and drive out less effective drugs. But critics say the approach is risky and a distraction from other efforts to fight the disease.
-
By tracking nearly 15 million cellphones in Kenya, scientists mapped out how malaria spreads through the Texas-sized country. The findings pinpoint areas where efforts to control malaria would be the most effective. One day, the data may help guide alert systems for phones that remind travelers to use bed nets.
-
An experimental program by the Global Fund brought more than 100 million malaria treatments to people in sub-Saharan Africa last year, a panel of public health experts said on Monday. But time may have run out for the program to prove it's worth continuing as the Global Fund's budget declines.
-
As a captain in the U.S. Army during World War II, Theodor Geisel created a booklet warning troops against the dangers of malaria and how to avoid contracting it.
-
An international team of researchers based in the U.K. say they've taken a big step forward in tracking the malaria parasite's evolution and predicting hotspots of potential resistance.